Matinas BioPharma Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Schedule of Outstanding Options Exercise Price (Details)	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Number of options outstanding \| shares	17,529,000
Weighted Average Exercise Price Per Share	$ 1.11
Exercise Price One [Member]
Exercise price, minimum	0.41
Exercise price, maximum	$ 0.63
Number of options outstanding \| shares	2,920,000
Weighted Average Exercise Price Per Share	$ 0.45
Exercise Price Two [Member]
Exercise price, minimum	0.68
Exercise price, maximum	$ 1.12
Number of options outstanding \| shares	10,279,000
Weighted Average Exercise Price Per Share	$ 0.94
Exercise Price Three [Member]
Exercise price, minimum	1.24
Exercise price, maximum	$ 1.95
Number of options outstanding \| shares	2,863,000
Weighted Average Exercise Price Per Share	$ 1.33
Exercise Price Four [Member]
Exercise price, minimum	2.74
Exercise price, maximum	$ 3.32
Number of options outstanding \| shares	1,467,000
Weighted Average Exercise Price Per Share	$ 3.25